http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0162924-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_692dc75829481c48c017b52f352e2bad
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-553
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-553
filingDate 1984-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1fcde0422ce6e67f783060426bb338a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67a4d17813d2e85e4026ef8b8f88757a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d924f2c203ae14776ca7d73b2cb3b647
publicationDate 1987-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0162924-A4
titleOfInvention 5-FLUORURACILA COMBS AND MEDICAL COMPOSITIONS CONTAINING THEM.
abstract 5-Fluorouracil derivatives represented by general formula (I): (wherein R represents an acyl group derived from an unsaturated higher fatty acid selected from the group consisting of triene higher fatty acids, pentaene higher fatty acids, and hexaene higher fatty acids) can be used as an agent for controlling platelet agglutination and a carcinostatic agent. They may be mixed with a pharmaceutically acceptable carrier or a diluente to form a medicinal preparation.
priorityDate 1983-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414898412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410822139

Total number of triples: 20.